Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kyle Rove to Urinary Bladder Neoplasms

This is a "connection" page, showing publications Kyle Rove has written about Urinary Bladder Neoplasms.

 
Connection Strength
 
 
 
0.941
 
  1. Rove KO, Husmann DA, Wilcox DT, Vricella GJ, Higuchi TT. Systematic review of bladder cancer outcomes in patients with spina bifida. J Pediatr Urol. 2017 Oct; 13(5):456.e1-456.e9.
    View in: PubMed
    Score: 0.446
  2. Rove KO, Higuchi TT. Monitoring and malignancy concerns in patients with congenital bladder anomalies. Curr Opin Urol. 2016 07; 26(4):344-50.
    View in: PubMed
    Score: 0.419
  3. Deb AA, Wilson SS, Rove KO, Kumar B, Koul S, Lim DD, Meacham RB, Koul HK. Potentiation of mitomycin C tumoricidal activity for transitional cell carcinoma by histone deacetylase inhibitors in vitro. J Urol. 2011 Dec; 186(6):2426-33.
    View in: PubMed
    Score: 0.076
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)